Contact Us

Lifesite Dialysis
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



What medical condition prompted the use of the device?

Date Dialysis treatment started:

Is Dialysis treatment still underway?

If no, date Dialysis treatment ended:

Please describe any problems or injuries caused by the product:

Date adverse symptoms or injuries were noticed:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Lifesite Dialysis

Lifesite Dialysis Side Effects Lawsuits | Side Effects: Deaths, Serious Injury | Defective Medical Equipment, Device Malfunctioned

Lifesite Dialysis Side Effects Could Result In Personal Injury Lawsuits

Lifesite Dialysis | Lawsuits, Lawyers | Side Effects: Deaths, Serious Injury | Defective Medical Equipment, Device Malfunctioned

A kidney dialysis device made by Vasca Inc. has been the subject of 129 complaints involving death or injuries since it went on the market in 1998, federal regulators say. In a letter sent to the Tewksbury-based company on Nov. 29, the Food and Drug Administration accused the company of reporting some incidents late and not investigating some deaths properly, The Patriot Ledger reported Thursday.

The device, LifeSite, is implanted under the skin and connects a dialysis machine to the patients blood vessels so the machine can remove wastes from the blood and return cleaned blood to the patient. LifeSite reduced including infection and blood clots side effects that are associated with dialysis, the company said. But in its letter, the FDA said it found 129 complaints in the company's files involving deaths or serious injuries. Thomas Glover, president of Vasca, said patients eligible to use the device are extremely ill.

But in 20 cases, FDA investigators ``found information to reasonably suggest'' the device ``may have caused or contributed to a death or injury'' or that the device malfunctioned in a way that could hurt a patient if the problem recurred, the letter said.

The company filed 14 of the 20 reports with the FDA after a 30-day time limit and did not file six reports at all, the FDA said. The letter, which was posted on the FDA's Web site, warned that the agency will take regulatory action if the company doesn't address the problems.

Glover said the company has responded to the letter and is in discussions with the FDA. He said the paperwork problems came from a misunderstanding of agency regulations. "There were things that we didn't think had to be reported,'' he said. ``So some of our reports were late.'' About 3,000 patients in the United States have used LifeSite since the FDA approved it last year, Glover said. The device was approved in Canada in 1999 and in Europe in 1998.

Legal Help For Victims Affected By Lifesite Dialysis

If you or a loved one suffered injuries from a Lifesite dialysis machine, please fill out the form at the right for a free case evaluation by a qualified defective medical device attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).


Lifesite DialysisRSS Feed

Vasca Responds to Filing of Lawsuit

Jun 26, 2002
Vasca, Inc., the developer, manufacturer and marketer of the LifeSite® Hemodialysis Access System, announced today that it has been named in a lawsuit filed in California on behalf of a LifeSite patient. The suit asserts claims arising out of Vasca’s sale of the LifeSite System, including claims based on matters raised in an FDA Warning Letter issued to the company in November 2001.The November 2001 Warning Letter includes issues on the complaint handling system and the timing of...

More Lifesite Dialysis News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo